Begin main content

Search

We found 48 result(s)

CDR Update — Issue 127

Last Updated: September 11, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Extended Initiation Range for January 2018 CDEC Meeting CADTH has extended the initiation range for its Common Drug Review (CDR) submissions targeting the January 17, 2018 Canadian Drug Expert Committee (CDEC) meeting. Reviews initiated by September 20, 2017 will target the January 2018 CDEC meeting (revised from September 11, 2017). 2. Pharm...

CDR Update — Issue 126

Last Updated: August 14, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Extended Initiation Range for December 2017 CDEC Meeting CADTH has extended the initiation range for Common Drug Review (CDR) submissions targeting the December 13, 2017 Canadian Drug Expert Committee (CDEC) meeting. Reviews initiated by August 23, 2017 will target the December 2017 CDEC meeting (revised from August 14, 2017). This revision h...

CDR Update — Issue 125

Last Updated: August 1, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Sharing Patient Input Submissions for the CDR Program Since February 2014, CADTH has shared patient input submissions on our website, when permission has been given by the patient group providing the input.  Sharing the groups’ original submissions has allowed all to read how perspectives and experiences were expressed in the groups’ own word...

CDR Update — Issue 124

Last Updated: July 13, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. CDEC Meeting Added in December 2017 and Updated CDEC Meeting Dates CADTH will be holding a Canadian Drug Expert Committee (CDEC) meeting in December 2017 and has posted an updated table with the targeted CDEC meeting dates on the CADTH website. 2. CADTH Consultation: Proposed Revision to the Procedure for the CADTH Common Drug Review and the ...

CDR Update — Issue 123

Last Updated: June 13, 2017
Result type: Reports
Product Line: CDR Update Newsletter

Introducing New Patient Input Template and Integrating Companion Diagnostic Assessment Into CADTH’s Drug Review Programs CADTH would like to thank all stakeholders who responded to the consultation on the proposed changes to: the patient input template for the CADTH Common Drug Review (CDR) and the CADTH pan-Canadian Oncology Drug Review (pCODR)...

CDR Update — Issue 122

Last Updated: June 9, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Revised Advanced Notification Process for CADTH Common Drug Review 1.1 Drugs Undergoing Expedited Health Canada Review CADTH issued a new advanced notification process for the Common Drug Review (CDR) in September 2016. Stakeholders have recently communicated that it can be challenging to provide 120 days of advanced notification in situation...

CDR Update — Issue 121

Last Updated: April 17, 2017
Result type: Reports
Product Line: CDR Update Newsletter

1. Expanding CADTH’s Drug Review Processes to Include Radiopharmaceuticals In collaboration with the participating jurisdictions, CADTH is pleased to announce that it will accept submissions for radiopharmaceuticals used for therapeutic purposes (i.e., not for diagnostic purposes) for review through the CADTH Common Drug Review (CDR) and the CAD...

CDR Update — Issue 120

Last Updated: November 18, 2016
Result type: Reports
Product Line: CDR Update Newsletter

Consultation on CADTH’s Proposed Process for the Assessment of Companion Diagnostics Call for Feedback Deadline: January 13, 2017, at 5:00 p.m. ET via email to: feedback@cadth.ca   CADTH is inviting stakeholder comments and feedback on the following proposed process for the assessment of companion diagnostics through the CADTH Common Drug Review...

CDR Update — Issue 119

Last Updated: May 26, 2016
Result type: Reports
Product Line: CDR Update Newsletter

1. CADTH Common Drug Review and pan-Canadian Oncology Drug Review Engagement with the pan-Canadian Pharmaceutical Alliance CADTH would like to inform its stakeholders that we are formally engaging with the pan-Canadian Pharmaceutical Alliance (pCPA) office, and effective immediately will be including the pCPA office in the CADTH Common Drug Revi...

CDR Update - Issue 118

Last Updated: March 24, 2016
Result type: Reports
Product Line: CDR Update Newsletter

1. Introducing a Common CADTH Recommendation Framework and Establishing a Minimum Period of 120 Calendar Days for Advance Notification of Anticipated Submissions and Resubmissions for CADTH Common Drug Review and pan-Canadian Oncology Drug Review Programs CADTH would like to thank all stakeholders who responded to our recent consultations. Regar...